EMA Answers Drugmakers’ Brexit Questions on Transfers and Relocations

The European Medicines Agency says marketing authorization holders must be based in the European Economic Area post-Brexit — and UK-based companies will likely need to transfer marketing authorizations to new addressees.
Source: Drug Industry Daily